Projected Income Statement: CSL Limited

Forecast Balance Sheet: CSL Limited

Forecast Balance Sheet - CSL Limited
Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 -779 10,679 10,526 8,981 9,383 9,217 8,821 8,224
Change - 1,470.86% -1.43% -14.68% 4.48% -1.77% -4.3% -6.77%
Announcement Date 8/16/22 8/14/23 8/12/24 8/18/25 8/17/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 1,079 1,228 849 636 646 950.8 1,051 1,081
Change - 13.83% -30.86% -25.09% 1.57% 47.18% 10.55% 2.83%
Free Cash Flow (FCF) 1 1,550 1,373 1,915 2,925 2,866 3,145 2,935 3,085
Change - -11.41% 39.48% 52.74% -2.02% 9.73% -6.68% 5.12%
Announcement Date 8/16/22 8/14/23 8/12/24 8/18/25 8/17/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 34.04% 29.3% 32.09% 33.11% 28.09% 32.28% 32.65% 32.93%
EBIT Margin (%) 27.72% 23.06% 25.76% 28.72% 29.25% 27.7% 28.15% 28.38%
EBT Margin (%) 26.32% 20.01% 22.8% 23.94% -25.87% 23.44% 25.11% 25.44%
Net margin (%) 21.35% 16.48% 17.85% 19.3% -16.33% 17.88% 19.28% 19.68%
FCF margin (%) 14.67% 10.32% 12.94% 18.8% 18.14% 19.96% 17.99% 18.14%
FCF / Net Income (%) 68.74% 62.58% 72.48% 97.44% -111.13% 111.61% 93.33% 92.2%

Profitability

        
ROA 9.7% 6.79% 7.12% 7.75% -7.06% 10.7% 10.85% 10.55%
ROE 19.64% 14.45% 15.94% 16.36% -15.11% 19.19% 18.93% 18.56%

Financial Health

        
Leverage (Debt/EBITDA) - 2.74x 2.22x 1.74x 2.11x 1.81x 1.66x 1.47x
Debt / Free cash flow - 7.78x 5.5x 3.07x 3.27x 2.93x 3.01x 2.67x

Capital Intensity

        
CAPEX / Current Assets (%) 10.21% 9.23% 5.74% 4.09% 4.09% 6.03% 6.44% 6.36%
CAPEX / EBITDA (%) 30% 31.49% 17.87% 12.35% 14.56% 18.69% 19.74% 19.3%
CAPEX / FCF (%) 69.6% 89.44% 44.33% 21.74% 22.54% 30.23% 35.82% 35.03%

Items per share

        
Cash flow per share 1 5.592 5.375 5.697 7.324 7.287 7.38 7.961 8.418
Change - -3.87% 5.98% 28.56% -0.51% 1.28% 7.88% 5.74%
Dividend per Share 1 2.22 2.36 2.64 2.92 2.92 3 3.184 3.416
Change - 6.31% 11.86% 10.61% 0% 2.75% 6.13% 7.3%
Book Value Per Share 1 30.26 32.73 35.93 39.93 30.9 33.47 36.6 40.21
Change - 8.14% 9.79% 11.14% -22.62% 8.31% 9.36% 9.87%
EPS 1 4.8 4.53 5.45 6.17 -5.35 6.064 6.716 7.068
Change - -5.62% 20.31% 13.21% -186.71% 213.35% 10.75% 5.23%
Nbr of stocks (in thousands) 481,706 482,372 483,253 484,212 478,912 478,912 478,912 478,912
Announcement Date 8/16/22 8/14/23 8/12/24 8/18/25 8/17/26 - - -
1USD
Estimates
2027 *2028 *
P/E 22.9x 20.7x
PBR 4.15x 3.8x
EV / Sales 4.81x 4.62x
Yield 2.16% 2.29%

EPS & Dividend

EPS & Dividend - CSL Limited


Y-o-Y evolution of P/E

Valuation ratios - P/E - CSL Limited
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - CSL Limited
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CSL Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.94USD
Average target price
135.03USD
Spread / Average Target
-2.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CSL Limited
  1. Stock Market
  2. Stocks
  3. CSL Stock
  4. Financials CSL Limited